Skip to main content
. 2021 Oct 1;20:15330338211042139. doi: 10.1177/15330338211042139

Table 3.

Medical complications (episodes) after start of liposomal doxorubicin. (no. p. = number of patients, LFP = liver function parameters).

Medical complications Number of events Percentage (%) of patients
Median number of admissions 1
Cardiotoxicity 0 0
Grade III or IV neutropenia 3 11
Infection requiring admission 4 14
Nausea 1 4
Increase of LFP 1 4
Alopecia 1 4